Skip to main content

Full text of "Situation report - 26"

See other formats


Coronavirus disease 2019 (COVID-19) 

Situation Report - 26 


/ World Health 


Organization 


Data as reported by 15 February 2020* 


HIGHLIGHTS 

• Egypt reported its first confirmed case of COVID-19. This is the second country 
in the WHO EMRO region to confirm a case, and the first reported case from 
the African continent. WHO was informed by the Egyptian Ministry of Health 
and Population. More information (in Arabic) can be found in a joint media 
statement from the Ministry and WHO. 


SITUATION IN NUMBERS 

total and new cases in last 24 
hours 

Globally 

50 580 laboratory-confirmed 
(1527 new) 


• In a speech to the Munich Security Conference, the WHO Director-General, 
Dr. Tedros Adhanom Ghebreyesus, described aspects of the COVID-19 
outbreak situation that WHO finds encouraging, and areas of concern. Details 
can be found here . 

• WHO regional offices continue to support countries with their COVID-19 
readiness efforts. More information can be found about the efforts in each of 
the regions here: Africa: Americas: South-East Asia: Europe: Eastern 
Mediterranean: and Western Pacific . 


China 

50 054 laboratory-confirmed 
(1506 new) 

1524 deaths (121 new)'*’ 

Outside of China 

526 laboratory-confirmed 
(21 new) 

25 countries (1 new) 

2 deaths 


WHO RISK ASSESSMENT 

China Very High 

Regional Level High 
Global Level High 


Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19,15 February 2020 



Republic 
of Korea 


LUnit^rAro b 

Ibmir^tes^ 


-Thailariq. 


Sri Lanka 


Combodi 


'China 


Distribution of COVID-19 cases as of 15 February 2020 


. _ y.^^'^Finland 

Sweden t 

^ } 

UniteST ,*■ 

^ ^Kingdb 

Belgium jif ^ 

• G.er lnbh yJ 

.w • 

S()ain • Italy 


Russian 

Federation 


Canada 


United States 


Japan 




Malaysia 

' TV 


Singapore 


Australia 


50 ■5000 


Number of 
Confirmed cases 


Country, area or territory 
with cases* 


Oota Source: World Healfh Organizafion, National 
Health Commission of the People's Republic of China 
Map Production: WHO Health Emergencies Programme 


*An additional 2 18 


cases are 


identified on a cruise ship currently in Japanese territorial waters. 


eWorld HeathOrganzaOon 2020, All rghts reserved. 


*The situation report inciudes information provided by nationai authorities as of 10 AM Centrai European Time 
tAs reported by China 


























SURVEILLANCE 


Table 1. Confirmed and suspected cases of COVID-19 acute respiratory disease reported by provinces, regions and 
cities in China, 15 February 2020* 


Province/ 




Daily 




Cumulative 


Region/ 

City 

Population 

{10,000s) 

Laboratory 

confirmed 

Clinically 

diagnosed 

Total 

cases 

Suspected 

cases 

Deaths 

Laboratory 

confirmed 

Clinically 

diagnosed 

Total 

cases 

Deaths 

Hubei 

5917 

1282 

1138 

2420 

1216 

139 

37884 

16522 

54406 

1457 

Guangdong 

11346 

33 

- 

33 

9 

0 

1294 

- 

1294 

2 

Henan 

9605 

28 

- 

28 

153 

2 

1212 

- 

1212 

13 

Zhejiang 

5737 

7 

- 

7 

23 

0 

1162 

- 

1162 

0 

Hunan 

6899 

13 

- 

13 

50 

0 

1001 

- 

1001 

2 

Anhui 

6324 

16 

- 

16 

13 

0 

950 

- 

950 

6 

Jiangxi 

4648 

13 

- 

13 

21 

0 

913 

- 

913 

1 

Jiangsu 

8051 

11 

- 

11 

3 

0 

604 

- 

604 

0 

Chongqing 

3102 

8 

- 

8 

98 

1 

537 

- 

537 

5 

Shandong 

10047 

11 

- 

11 

27 

0 

530 

- 

530 

2 

Sichuan 

8341 

7 

- 

7 

72 

0 

470 

- 

470 

1 

Heilongjiang 

3773 

7 

- 

7 

48 

0 

425 

- 

425 

11 

Beijing 

2154 

3 

- 

3 

51 

1 

375 

- 

375 

4 

Shanghai 

2424 

8 

- 

8 

87 

0 

326 

- 

326 

1 

Hebei 

7556 

8 

- 

8 

8 

0 

291 

- 

291 

3 

Fujian 

3941 

4 

- 

4 

6 

0 

285 

- 

285 

0 

Guangxi 

4926 

9 

- 

9 

44 

0 

235 

- 

235 

2 

Shaanxi 

3864 

2 

- 

2 

37 

0 

232 

- 

232 

0 

Yunnan 

4830 

6 

- 

6 

39 

0 

168 

- 

168 

0 

Hainan 

934 

5 

- 

5 

36 

0 

162 

- 

162 

4 

Guizhou 

3600 

3 

- 

3 

4 

0 

143 

- 

143 

1 

Shanxi 

3718 

1 

- 

1 

12 

0 

127 

- 

127 

0 

Tianjin 

1560 

1 

- 

1 

128 

0 

120 

- 

120 

3 

Liaoning 

4359 

2 

- 

2 

66 

0 

119 

- 

119 

1 

Gansu 

2637 

0 

- 

0 

4 

0 

90 

- 

90 

2 

Jilin 

2704 

2 

- 

2 

8 

0 

88 

- 

88 

1 

Ningxia 

688 

3 

- 

3 

3 

0 

70 

- 

70 

0 

Xinjiang 

2487 

5 

- 

5 

4 

0 

70 

- 

70 

1 

Inner Mongolia 

2534 

5 

- 

5 

7 

0 

68 

- 

68 

0 

Hong Kong Sar 

745 

3 

- 

3 

0 

0 

56 

- 

56 

1 

Taipei and environs 

2359 

0 

- 

0 

0 

0 

18 

- 

18 

0 

Qinghai 

603 

0 

- 

0 

0 

0 

18 

- 

18 

0 

Macao Sar 

66 

0 

- 

0 

0 

0 

10 

- 

10 

0 

Xizang 

344 

0 

- 

0 

0 

0 

1 

- 

1 

0 

Total 

142823 

1506 

1138 

2644 

2277 

143 

50054 

16522 

66576 

1524 


'Deaths in table 1 include both lab-confirmed cases and clinically diagnosed cases of COVID-19. 


















































Table 2. Countries, territories or areas outside China with reported laboratory-confirmed COVID-19 cases and 
deaths. Data as of 15 February 2020 



'Case classifications are based on WHO case definitions for COVID-19. 

^Location of transmission is classified based on WHO analysis of available official data and may be subject to reclassification as additional data 
become available. 

♦Confirmed cases in China include cases confirmed in Hong Kong SAR (56 confirmed cases, 1 death), Macao SAR (10 confirmed cases) and Taipei 
and environs (18 confirmed cases). 

"Cases identified on a cruise ship currently in Japanese territorial waters. 

^The exposure for 2 cases occurred outside of Spain. 

"'The exposure for 6 cases occurred outside of the United Kingdom. 
s^The exposure for 3 cases occurred outside of Republic of Korea. 

♦♦The exposure for 1 case occurred outside of Malaysia. One patient also had travel history to China, but exposure likely occurred after return to 
Malaysia. 












































Figure 2. Epidemic curve of COVID-19 cases (n=204) identified outside of China, by date of onset of symptoms and 
travel history, 15 February 2020 



Date of symptom onset 


Travel exposure history 


□ 

■ 

■ 

□ 


No travel 

Country other than China 
Under investigation 
China (location unknown) 
China (not Hubei) 

China (Hubei province) 


Note for figure 2: Of the 526 cases reported outside China, 18 were detected while apparently asymptomatic. For 
the remaining 508 cases, information on date of onset is available only for the 204 cases presented in the 
epidemiologic curve. 


Figure 3. Epidemic curve of COVID-19 cases (n=526) identified outside of China, by date of reporting and travel 
history, 15 February 2020 



2019 2020 2020 2020 2020 2020 2020 

Date of report 


Travel exposure history 


□ 

■ 

■ 

■ 

□ 


No travel 

International conveyance 
Country other than China 
Under investigation 
China (location unknown) 
China (not Hubei) 

China (Hubei province) 

















































STRATEGIC OBJECTIVES 

WHO's strategic objectives for this response are to: 

• Limit human-to-human transmission including reducing secondary infections among close contacts and 
health care workers, preventing transmission amplification events, and preventing further international 
spread from China*; 

• Identify, isolate and care for patients early, including providing optimized care for infected patients; 

• Identify and reduce transmission from the animal source; 

• Address crucial unknowns regarding clinical severity, extent of transmission and infection, treatment 
options, and accelerate the development of diagnostics, therapeutics and vaccines; 

• Communicate critical risk and event information to all communities and counter misinformation; 

• Minimize social and economic impact through multisectoral partnerships. 

*This can be achieved through a combination of public health measures, such as rapid identification, diagnosis 
and management of the cases, identification and follow up of the contacts, infection prevention and control in 
health care settings, implementation of health measures for travelers, awareness-raising in the population and 
risk communication. 


PREPAREDNESS AND RESPONSE 

• To view all technical guidance documents regarding COVID-19, please go to this webpage . 

• WHO is working closely with International Air Transport Association (lATA) and have jointly developed a 
guidance document to provide advice to cabin crew and airport workers, based on country queries. The 
guidance can be found on the lATA webpage . 

• WHO has developed a protocol for the investigation of early cases (the " First Few X (FFX) Cases and contact 
investigation protocol for 2019-novel coronavirus (2019-nCoV) infection "). The protocol is designed to gain an 
early understanding of the key clinical, epidemiological and virological characteristics of the first cases of COVID- 
19 infection detected in any individual country, to inform the development and updating of public health 
guidance to manage cases and reduce potential spread and impact of infection. 

• WHO has been in regular and direct contact with Member States where cases have been reported. WHO is also 
informing other countries about the situation and providing support as requested. 

• WHO has developed interim guidance for laboratory diagnosis, advice on the use of masks during home care and 
in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak, clinical management, 
infection prevention and control in health care settings, home care for patients with suspected novel 

coronavirus, risk communication and community engagement and Global Surveillance for human infection with 
novel coronavirus (2019-nCoV). 

• WHO has prepared disease commodity package that includes an essential list of biomedical equipment, 
medicines and supplies necessary to care for patients with 2019-nCoV. 

• WHO has provided recommendations to reduce risk of transmission from animals to humans . 

• WHO has published an updated advice for international traffic in relation to the outbreak of the novel 
coronavirus 2019-nCoV . 

• WHO has activated of R&D blueprint to accelerate diagnostics, vaccines, and therapeutics. 

• WHO has developed an online course to provide general introduction to emerging respiratory viruses, including 
novel coronaviruses. 

• WHO is providing guidance on early investigations, which are critical to carry out early in an outbreak of a new 
virus. The data collected from the protocols can be used to refine recommendations for surveillance and case 
definitions, to characterize the key epidemiological transmission features of COVID-19, help understand spread, 
severity, spectrum of disease, impact on the community and to inform operational models for implementation of 






















countermeasures such as case isolation, contact tracing and isolation. Several protocols are available here: 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/earlv-investigations 

• WHO is working with its networks of researchers and other experts to coordinate global work on surveillance, 
epidemiology, modelling, diagnostics, clinical care and treatment, and other ways to identify, manage the 
disease and limit onward transmission. WHO has issued interim guidance for countries, which are updated 
regularly. 

• WHO is working with global expert networks and partnerships for laboratory, infection prevention and control, 
clinical management and mathematical modelling. 


RECOMMENDATIONS AND ADVICE FOR THE PUBLIC 

During previous outbreaks due to other coronavirus (Middle-East Respiratory Syndrome (MERS) and Severe 
Acute Respiratory Syndrome (SARS), human-to-human transmission occurred through droplets, contact and 
fomites, suggesting that the transmission mode of the COVID-19 can be similar. The basic principles to reduce the 
general risk of transmission of acute respiratory infections include the following: 

• Avoiding close contact with people suffering from acute respiratory infections. 

• Frequent hand-washing, especially after direct contact with ill people or their environment. 

• Avoiding unprotected contact with farm or wild animals. 

• People with symptoms of acute respiratory infection should practice cough etiquette (maintain distance, cover 
coughs and sneezes with disposable tissues or clothing, and wash hands). 

• Within health care facilities, enhance standard infection prevention and control practices in hospitals, especially 
in emergency departments. 

WHO does not recommend any specific health measures for travellers. In case of symptoms suggestive of respiratory 
illness either during or after travel, travellers are encouraged to seek medical attention and share their travel history 
with their health care provider.